Try GOLD - Free

H-word, M-word & fading K-word

Business Standard

|

June 14, 2025

If the only superpower, which calls India an ally, sees the region through an India-Pakistan prism, it is unacceptable. Rather than endorse India's sphere of influence, this undermines it

- SHEKHAR GUPTA

H-word, M-word & fading K-word

Much as I would've wanted to use "khota sikka", the challenge of finding an exact translation brings me to the usual bad penny. Let's say, therefore, that like a bad penny, the dreaded H-word is back with us — H, as in hyphenation with Pakistan.

And its return is dreaded because our successive governments have laboured for three decades to rid us of what we see as the equivalence the big powers (read the United States) used to draw between us and Pakistan. Three things follow.

Let's call the first the "zero-sum game". If Washington sees the subcontinent in a hyphenated manner, then it must balance the relationship. Gain for one is loss for the other. It brings an equivalence India detests. It believes it stands in a class by itself and linking with Pakistan demeans it.

The second can be called "stature denial". Given its growing comprehensive national power (CNP), India believes it deserves a sphere of influence. If Washington, an ally, sees the region through an India-Pakistan prism, it's unacceptable. Rather than endorse India's sphere of influence, this undermines it.

This is double trouble as China is already working hard at denying India that pre-eminence. And whereas India would expect US backing in this competition, it is galling when the US keeps saying sweet somethings to Pakistan. We thought we were partners in a project to contain China through Quad.

And the third, this means the return of the M-word that so triggers us — M for mediation. For Indian public opinion, American President Donald Trump has undone the work of the past decades by continuing to insist that he mediated the India-Pakistan ceasefire. Now, we know that his interest isn't in any mediation but in getting credit: "Nobody gives me credit for stopping a nuclear war", "I stopped a nuclear war and I haven't seen any stories about it", and so on.

MORE STORIES FROM Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size